(1S,3R,4R)-3-((tert-butoxycarbonyl)amino)bicyclo[2.1.0]pentane-1-carboxylic acid

Catalog No.: 
ACTMJX672
CAS No.: 
2248307-21-1
Molecular Formula: 
C11H17NO4
Molecular Weight: 
227.26
(1S,3R,4R)-3-((tert-butoxycarbonyl)amino)bicyclo[2.1.0]pentane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$342.00InquiryInquiry
250mg98%$547.00InquiryInquiry
1g98%$1368.00InquiryInquiry
5g98%$4104.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,3R,4R)-3-((tert-butoxycarbonyl)amino)bicyclo[2.1.0]pentane-1-carboxylic acid
IUPAC Name(1S,3R,4R)-3-((tert-butoxycarbonyl)amino)bicyclo[2.1.0]pentane-1-carboxylic acid
Molecular FormulaC11H17NO4
Molecular Weight227.26
SMILESCC(C)(C)OC(=O)N[C@@H]1C[C@@]2(C(=O)O)C[C@@H]12
InChI KeyXSVGLLRLSSSGEL-CVJICSNFSA-N
Synonym(1S,3R,4R)-3-[(2-methylpropan-2-yl)oxycarbonylamino]bicyclo[2.1.0]pentane-1-carboxylic acid;endo-3-(tert-butoxycarbonylamino)bicyclo[2.1.0]pentane-1-carboxylic acid;Rel-(1S,3R,4R)-3-((tert-butoxycarbonyl)amino)bicyclo[2.1.0]pentane-1-carboxylic acid
CAS No.2248307-21-1

Synthetic Route by SureRoute

1. ACTMJX672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTMJX672 route product structure diagram
    ACTMJX6722248307-21-1
Inquiry

2. ACTMJX672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTMJX672 route product structure diagram
    ACTMJX6722248307-21-1
Inquiry

3. ACTMJX672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMJX672 route product structure diagram
    ACTMJX6722248307-21-1
Inquiry

Comments (0)